Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression (Q35930081)

11 August 2017

Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression (English)

1 reference

Erratum to: Age, atherosclerosis and type 2 diabetes reduce human mesenchymal stromal cell-mediated T-cell suppression

11 August 2017

1 reference

1 reference

corrigendum / erratum

1 reference

10.1186/S13287-017-0504-7

Crossref

DOI

12 July 2019

http://api.crossref.org/works?select=update-to&filter=doi:10.1186/S13287-017-0504-7

author name string

Ozge Kizilay Mancini

1

1 reference

11 August 2017

Dominique Shum-Tim

2

1 reference

11 August 2017

Ursula Stochaj

3

1 reference

11 August 2017

José A Correa

4

1 reference

11 August 2017

Inés Colmegna

5

1 reference

11 August 2017

8 August 2015

1 reference

Stem Cell Research & Therapy

11 August 2017

1 reference

11 August 2017

6

1 reference

11 August 2017

140

1 reference

Use of mesenchymal stem cells for therapy of cardiac disease

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4529693

Lymphocytes in atherosclerosis

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4529693

A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4529693

Do cryopreserved mesenchymal stromal cells display impaired immunomodulatory and therapeutic properties?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4529693

Inositol pyrophosphates mediate the effects of aging on bone marrow mesenchymal stem cells by inhibiting Akt signaling

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4529693

Adipose-derived mesenchymal stromal cells from aged patients with coronary artery disease keep mesenchymal stromal cell properties but exhibit characteristics of aging and have impaired angiogenic potential

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4529693

Cardiovascular Disease Risk Assessment: Insights from Framingham

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4529693

Effector Memory T cells Are Associated With Atherosclerosis in Humans and Animal Models

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4529693

Harnessing the mesenchymal stem cell secretome for the treatment of cardiovascular disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4529693

Increased expression of pigment epithelium-derived factor in aged mesenchymal stem cells impairs their therapeutic efficacy for attenuating myocardial infarction injury

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4529693

Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4529693

Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4529693

Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina: one-year follow-up

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4529693

Circulating CD14-CD36+ peripheral blood mononuclear cells constitutively produce interleukin-10.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4529693

Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study

24 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2FS13287-015-0127-9

First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction

21 January 2018

1 reference

12 December 2020

The suppressive effect of mesenchymal stromal cells on T cell proliferation is conserved in old age

1 reference

12 December 2020

Patients With Acute Coronary Syndrome Show Oligoclonal T-Cell Recruitment Within Unstable Plaque

1 reference

12 December 2020

Adipose-derived regenerative cells in patients with ischemic cardiomyopathy: The PRECISE Trial

1 reference

12 December 2020

Advanced age impairs cardioprotective function of mesenchymal stem cell transplantation from patients to myocardially infarcted rats

1 reference

12 December 2020

Long-term culture in vitro impairs the immunosuppressive activity of mesenchymal stem cells on T cells

1 reference

12 December 2020

10.1186/S13287-015-0127-9

Identifiers

DOI

1 reference

Dimensions Publication ID

11 August 2017

0 references

1 reference

11 August 2017

PubMed publication ID

26253429

1 reference